ArTS Archivio della ricerca di Trieste

ROVIELLO, GIANDOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.947
EU - Europa 3.767
AS - Asia 3.254
SA - Sud America 418
AF - Africa 71
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.478
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.871
PL - Polonia 1.721
SG - Singapore 1.245
CN - Cina 748
IT - Italia 494
HK - Hong Kong 347
SE - Svezia 342
BR - Brasile 328
VN - Vietnam 327
DE - Germania 200
FR - Francia 153
FI - Finlandia 151
RU - Federazione Russa 130
UA - Ucraina 126
KR - Corea 121
TR - Turchia 116
GB - Regno Unito 115
IN - India 92
IE - Irlanda 77
BG - Bulgaria 71
NL - Olanda 54
CA - Canada 40
AR - Argentina 35
JP - Giappone 32
ES - Italia 30
IQ - Iraq 30
MX - Messico 26
MA - Marocco 24
MY - Malesia 22
ID - Indonesia 21
BD - Bangladesh 20
BE - Belgio 18
PK - Pakistan 17
EC - Ecuador 15
IL - Israele 15
SA - Arabia Saudita 15
AT - Austria 14
CH - Svizzera 11
JO - Giordania 11
AE - Emirati Arabi Uniti 10
AU - Australia 10
GR - Grecia 10
CL - Cile 9
CO - Colombia 9
TN - Tunisia 9
IR - Iran 8
KE - Kenya 8
NP - Nepal 8
PH - Filippine 8
RO - Romania 8
TW - Taiwan 8
DZ - Algeria 7
EG - Egitto 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
NZ - Nuova Zelanda 6
PE - Perù 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
MD - Moldavia 5
PT - Portogallo 5
PY - Paraguay 5
TH - Thailandia 5
JM - Giamaica 4
LT - Lituania 4
NO - Norvegia 4
OM - Oman 4
SI - Slovenia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
AZ - Azerbaigian 3
BO - Bolivia 3
DK - Danimarca 3
LB - Libano 3
AL - Albania 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
RS - Serbia 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SN - Senegal 1
Totale 15.476
Salva come PNG Salva come JPEG
Città #
Warsaw 1.646
Fairfield 1.005
Ashburn 869
Singapore 812
Woodbridge 597
Houston 522
Wilmington 445
Seattle 427
Chandler 420
Cambridge 385
Ann Arbor 383
Hong Kong 334
San Jose 322
Beijing 213
Jacksonville 183
Santa Clara 177
Trieste 161
Princeton 141
Boardman 122
Seoul 108
Chicago 99
Ho Chi Minh City 97
Izmir 96
Columbus 94
Dallas 84
Helsinki 83
Dublin 77
Hefei 75
Los Angeles 74
Lauterbourg 73
Sofia 70
Moscow 63
Zgierz 58
San Diego 56
Hanoi 53
New York 53
Munich 51
The Dalles 49
Council Bluffs 47
Milan 45
Frankfurt am Main 43
Buffalo 36
Dearborn 36
Dong Ket 34
Bremen 32
London 26
Redwood City 25
São Paulo 25
Tokyo 23
Orem 22
Turku 21
Atlanta 20
Tianjin 20
Mumbai 19
Nuremberg 19
Phoenix 18
Shanghai 18
Casablanca 17
Brussels 16
Guangzhou 16
Chennai 15
Dongguan 15
Miano 15
Lappeenranta 14
San Francisco 14
Da Nang 13
Duino-Aurisina 13
Hangzhou 13
Nanjing 13
Toronto 13
Denver 12
Falls Church 12
Kunming 11
Montegaldella 11
Poplar 11
Amman 10
Amsterdam 10
Boston 10
Düsseldorf 10
Jinan 10
Norwalk 10
Rio de Janeiro 10
Rome 10
Tel Aviv 10
Des Moines 9
Fremont 9
Lahore 9
Redondo Beach 9
Shenzhen 9
Udine 9
Changsha 8
Decatur 8
Haiphong 8
Madrid 8
Montreal 8
Riyadh 8
Shenyang 8
Ankara 7
Cairo 7
Eagan 7
Totale 11.571
Salva come PNG Salva come JPEG
Nome #
Advances in systemic therapy for metastatic breast cancer: future perspectives 411
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene 393
Isolated testicular metastasis from prostate cancer 369
Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma 365
Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer 365
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma 353
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer 347
Bevacizumab in small cell lung cancer 346
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer 343
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility 335
Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials 312
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma 303
Corticosteroid switch after progression on abiraterone acetate plus prednisone 293
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 283
Apatinib for the treatment of gastric cancer 275
Advances in systemic therapy for malignant mesothelioma: Future perspectives 272
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy 267
Lenvatinib for the treatment of renal cell carcinoma 263
Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer 247
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis 242
Immune checkpoint inhibitors in pre-treated gastric cancer patients: Results from a literature-based meta-analysis 232
Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis 231
The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials 225
Is there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer? 224
Results from a meta-analysis of immune checkpoint inhibitors in first-line renal cancer patients: does PD-L1 matter? 220
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 218
Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer? 216
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 215
Influence of Age and the Gleason Score in the Choice of Novel Hormonal Therapies before and after Chemotherapy 213
Tumour Infiltrating Lymphocytes and Immune-Related Genes as Predictors of Outcome in Pancreatic Adenocarcinoma 209
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 206
Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer? 199
Different efficacy of ramucirumab in patients with metastatic gastric and gastroesophageal junction cancer according to ECOG performance status 198
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 194
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer 193
A Phase II study of olaparib in breast cancer patients: Biological evaluation from a 'window of opportunity' trial 185
Is still there a place for orteronel in management of prostate cancer? Data from a literature based meta-analysis of randomized trials 182
Pertuzumab therapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer 181
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer 178
Efficacy of extended aromatase inhibitors for hormone-receptor–positive breast cancer: A literature-based meta-analysis of randomized trials 175
Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer? 173
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience 161
Is the fatigue an adverse event of the second generation of hormonal therapy? Data from a literature-based meta-analysis 160
Lower urinary tract infections from external beam radiation therapy in prostate cancer: A single institution experience 160
Risk of hypertension with ramucirumab-based therapy in solid tumors: data from a literature based meta-analysis 155
Role of targeted agents in neuroendocrine tumors: Results from a meta-analysis 154
Familial aggregation of gastric cancer with microsatellite instability** 154
Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxel 152
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer 150
Is there a place for bevacizumab in patients with extensive-stage small cell lung cancer? 148
Avelumab in gastric cancer 148
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 147
No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials 146
Apatinib in metastatic gastric cancer: Can paclitaxel make the difference? 146
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis 146
Single Center Experience on Anatomy-and Histopathology-Based Gastric Cancer Molecular Classification 143
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 142
Neoadjuvant chemotherapy and radical radiotherapy associated with cetuximab for laryngeal cancer in a pancreas and renal recipient 137
Is the Gleason score the driver for the treatment decision-making of patients with castration-resistant prostate cancer in the new era of the anti-androgenic therapies? 135
New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials 135
Expanding treatment options for metastatic gastric cancer 134
Is it time for everolimus-based combination in castration-resistant prostate cancer? 134
Surgical management of advanced gastric cancer: An evolving issue 132
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 131
Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033 128
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature 126
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies 124
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 124
Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatment 120
Updates on the CDK4/6 inhibitory strategy and combinations in breast cancer 120
Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis 120
Cancer management during the COVID-19 world pandemic 115
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 112
Optimal primary end point in Phase II trials of immune checkpoint inhibitors for advanced solid cancers: An evolving issue 103
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials 100
Immune-gene signature: A new tool for patient selection for checkpoint inhibitors? 86
Current Trends in Liquid Biopsy Tracking Resistance in Molecular Breast Cancer-Targeted Therapies 79
P53 antibodies as a diagnostic marker for cancer: A meta-analysis 74
Effects of Whole Pelvic Radiotherapy on the Distribution of Lymphocyte Subpopulations in Prostate Cancer Patients 67
The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study 66
New-Generation Hormone Therapies in Nonmetastatic Castration-Resistant Prostate Cancer: Why, Who, When 59
DNA repair deficiency as circulating biomarker in prostate cancer 48
Totale 15.772
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.643
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.643
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021212 0 0 0 0 0 0 0 0 0 0 71 141
2021/2022853 78 75 58 40 8 70 53 33 129 117 61 131
2022/20231.247 108 144 129 184 110 212 14 103 157 14 46 26
2023/2024763 35 83 45 56 33 73 136 151 2 42 50 57
2024/20252.211 26 200 369 133 170 292 101 84 261 215 189 171
2025/20263.777 413 195 181 339 405 342 595 148 402 661 96 0
Totale 15.772